You are 3 steps away
from making better decisions

Serving leading biopharmaceutical companies globally:

Mallinckrodt
Colorcon
AstraZeneca
McKinsey
Dow
Johnson and Johnson

Last Updated: February 24, 2020

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 019243


Email this page to a colleague

See Plans and Pricing

« Back to Dashboard

NDA 019243 describes PROVENTIL, which is a drug marketed by Schering and 3m Drug Delivery and is included in six NDAs. Additional details are available on the PROVENTIL profile page.

The generic ingredient in PROVENTIL is albuterol sulfate. There are thirty-eight drug master file entries for this compound. Forty-three suppliers are listed for this compound. Additional details are available on the albuterol sulfate profile page.
Summary for 019243
Tradename:PROVENTIL
Applicant:Schering
Ingredient:albuterol sulfate
Patents:0
Formulation / Manufacturing:see details

Profile for product number 001

Active Rx/OTC/Discontinued:DISCNDosage:SOLUTION;INHALATIONStrengthEQ 0.5% BASE **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**
Approval Date:Jan 14, 1987TE:RLD:Yes

Profile for product number 002

Active Rx/OTC/Discontinued:DISCNDosage:SOLUTION;INHALATIONStrengthEQ 0.083% BASE **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**
Approval Date:Jan 14, 1987TE:RLD:Yes

Expired US Patents for NDA 019243

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Schering PROVENTIL albuterol sulfate SOLUTION;INHALATION 019243-002 Jan 14, 1987   Start Trial   Start Trial
Schering PROVENTIL albuterol sulfate SOLUTION;INHALATION 019243-001 Jan 14, 1987   Start Trial   Start Trial
Schering PROVENTIL albuterol sulfate SOLUTION;INHALATION 019243-002 Jan 14, 1987   Start Trial   Start Trial
Schering PROVENTIL albuterol sulfate SOLUTION;INHALATION 019243-001 Jan 14, 1987   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration

Complete Access Available with Subscription

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

McKinsey
AstraZeneca
Johnson and Johnson
McKesson
Mallinckrodt
Harvard Business School

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.